HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 15 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,844 | -1.7% | 62,500 | 0.0% | 0.00% | – |
Q2 2023 | $45,625 | +119965.8% | 62,500 | 0.0% | 0.00% | – |
Q1 2023 | $38 | +52.0% | 62,500 | 0.0% | 0.00% | – |
Q4 2022 | $25 | -100.0% | 62,500 | 0.0% | 0.00% | – |
Q3 2022 | $69,000 | +25.5% | 62,500 | 0.0% | 0.00% | – |
Q2 2022 | $55,000 | -54.9% | 62,500 | 0.0% | 0.00% | – |
Q1 2022 | $122,000 | -14.7% | 62,500 | 0.0% | 0.00% | – |
Q4 2021 | $143,000 | -21.0% | 62,500 | 0.0% | 0.00% | – |
Q3 2021 | $181,000 | – | 62,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RPO LLC | 81,705 | $159,000 | 0.05% |
CVI Holdings, LLC | 269,138 | $517,000 | 0.03% |
Sio Capital Management, LLC | 49,998 | $97,000 | 0.03% |
Alpine Global Management, LLC | 95,000 | $182,000 | 0.02% |
Exos Asset Management LLC | 27,151 | $53,000 | 0.02% |
TUDOR INVESTMENT CORP ET AL | 236,549 | $461,000 | 0.01% |
LMR Partners LLP | 50,000 | $353,000 | 0.00% |
P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $37,000 | 0.00% |
Diameter Capital Partners LP | 19,085 | $37,000 | 0.00% |
HRT FINANCIAL LP | 50,250 | $96,000 | 0.00% |